Featured Research

from universities, journals, and other organizations

Matripase Critical For Epithelial Function

Date:
September 28, 2009
Source:
American Journal of Pathology
Summary:
Scientists report that the serum protease matripase is required for global homeostasis of diverse epithelial tissues.

A group led by Dr. Thomas Bugge of the National Institutes of Health in Bethesda, MD reports that the serum protease matripase is required for global homeostasis of diverse epithelial tissues.

Epithelial cells line the surfaces of cavities and structures throughout the body. These cells have multiple general and organ-specific functions, including maintaining ion gradients, transporting molecules, secreting hormones and growth factors, and excluding pathogens.

The serum protease matripase plays a critical role in the function of epithelial cells in the skin; however, matripase is broadly expressed in different types of epithelial tissues. To explore the role of matripase on other epithelial tissues, List et al generated matripase-deficient mice. The loss of matripase was associated with severe organ dysfunction in multiple tissues; these epithelial tissues lost key epithelial functions.

The data by Dr. Bugge and colleagues "all strongly argue for a primary role of matriptase in tissue homeostasis, rather than a role in the restoration of homeostasis after chance injury to epithelial tissues. … This study has revealed an essential role of matriptase in the maintenance of global epithelial homeostasis in the mouse and has provided an important animal model for the further exploration of matriptase function in multiple physiological and pathological processes."


Story Source:

The above story is based on materials provided by American Journal of Pathology. Note: Materials may be edited for content and length.


Journal Reference:

  1. List et al. Epithelial Integrity Is Maintained by a Matriptase-Dependent Proteolytic Pathway. American Journal Of Pathology, 2009; 175 (4): 1453 DOI: 10.2353/ajpath.2009.090240

Cite This Page:

American Journal of Pathology. "Matripase Critical For Epithelial Function." ScienceDaily. ScienceDaily, 28 September 2009. <www.sciencedaily.com/releases/2009/09/090928095216.htm>.
American Journal of Pathology. (2009, September 28). Matripase Critical For Epithelial Function. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/2009/09/090928095216.htm
American Journal of Pathology. "Matripase Critical For Epithelial Function." ScienceDaily. www.sciencedaily.com/releases/2009/09/090928095216.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins